HarbourVest Partners LLC lifted its position in shares of Omega Therapeutics, Inc. (NASDAQ:OMGA – Free Report) by 32.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,512,110 shares of the company’s stock after purchasing an additional 865,051 shares […]
Omega Therapeutics (NASDAQ:OMGA – Get Free Report) and Exscientia (NASDAQ:EXAI – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, institutional ownership, profitability, analyst recommendations and valuation. Earnings and Valuation This table compares Omega Therapeutics […]
Omega Therapeutics, Inc. (NASDAQ:OMGA – Get Free Report) was the target of a significant growth in short interest during the month of July. As of July 15th, there was short interest totalling 1,630,000 shares, a growth of 15.6% from the June 30th total of 1,410,000 shares. Approximately 7.6% of the company’s stock are short sold. […]